Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, California 94080, United States.
Confluence, 4340 Duncan Avenue, Suite 400, St. Louis, Missouri 63110, United States.
Anal Chem. 2022 Jan 18;94(2):1230-1239. doi: 10.1021/acs.analchem.1c04463. Epub 2022 Jan 6.
With recent advances and success in several drugs designed to treat acute and chronic diseases, targeted covalent inhibitors show a resurgence in drug discovery. As covalent inhibition is time-dependent, the preferred quantitative potency metric of irreversible inhibitors is the second-order rate constant /, rather than IC. Here, we present the development of a mass spectrometry-based platform for rapid kinetic analysis of irreversible covalent inhibitors. Using a simple liquid handling robot for automated sample preparation and a solid-phase extraction-based RapidFire-MS system for rapid MS analysis, kinetic characterization of covalent inhibitors was performed in high throughput both by intact protein analysis and targeted multiple reaction monitoring (MRM). In addition, a bimolecular reaction model was applied to extract / in data fitting, providing tremendous flexibility in the experimental design to characterize covalent inhibitors with various properties. Using KRAS inhibitors as a test case, the platform was demonstrated to be effective for studying covalent inhibitors with a wide range of / values from single digit to 3 × 10 M s.
随着针对急性和慢性疾病的几种药物的最新进展和成功,靶向共价抑制剂在药物发现中重新兴起。由于共价抑制是时间依赖性的,不可逆抑制剂的首选定量效力度量标准是二级速率常数 k,而不是 IC。在这里,我们提出了一种基于质谱的平台,用于快速动力学分析不可逆共价抑制剂。使用简单的液体处理机器人进行自动化样品制备和基于固相萃取的 RapidFire-MS 系统进行快速 MS 分析,通过完整蛋白分析和靶向多重反应监测(MRM)以高通量方式对共价抑制剂进行动力学表征。此外,双分子反应模型被应用于 k 提取进行数据拟合,为具有各种特性的共价抑制剂的表征提供了极大的实验设计灵活性。使用 KRAS 抑制剂作为测试案例,该平台被证明可有效地用于研究具有从单个数字到 3×10 M s 范围的各种 k 值的共价抑制剂。